Clinical Trial Details
EORTC-26081
Back to Clinical Trials Database
Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 22-Dec-2010 |
Data management at EORTC | No |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 200 - All Groups: 585 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00887146 |
NCT number | NCT00887146 |
EudraCT | 2008-007295-14 |